These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19484763)

  • 1. Botulinum toxin: A noninvasive option for the symptomatic treatment of salivary gland stenosis - a case report.
    Kruegel J; Winterhoff J; Koehler S; Matthes P; Laskawi R
    Head Neck; 2010 Jul; 32(7):959-63. PubMed ID: 19484763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-surgical management of parotid gland and duct injuries: interest of botulinum toxin].
    Arnaud S; Batifol D; Goudot P; Yachouh J
    Ann Chir Plast Esthet; 2008 Feb; 53(1):36-40. PubMed ID: 17382446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frey syndrome secondary to submaxillectomy and botulinic treatment].
    Báez A; Paleari J; Durán MN; Rudy T; Califano I; Barbosa N; Parera IC
    Medicina (B Aires); 2007; 67(5):478-80. PubMed ID: 18051233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of gustatory sweating with botulinum toxin.
    Naumann M; Zellner M; Toyka KV; Reiners K
    Ann Neurol; 1997 Dec; 42(6):973-5. PubMed ID: 9403490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of sialorrhoea in neurological diseases with trans-dermic injections of botulinum toxin type A in the parotid glands].
    Carod Artal FJ
    Neurologia; 2003 Jun; 18(5):280-4. PubMed ID: 12768517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of botulinum toxin in the treatment of a parotid duct injury during Mohs surgery and review of management options.
    Krishnan RS; Clark DP; Donnelly HB
    Dermatol Surg; 2009 Jun; 35(6):941-7. PubMed ID: 19397665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M; Lowe NJ; Kumar CR; Hamm H;
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
    Banerjee KJ; Glasson C; O'Flaherty SJ
    Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections.
    Sankhla C; Jankovic J; Duane D
    Mov Disord; 1998 Jan; 13(1):150-4. PubMed ID: 9452341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
    Ellies M; Gottstein U; Rohrbach-Volland S; Arglebe C; Laskawi R
    Laryngoscope; 2004 Oct; 114(10):1856-60. PubMed ID: 15454785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of crocodile tears by injection of botulinum toxin into the lacrimal gland: a case report.
    Riemann R; Pfennigsdorf S; Riemann E; Naumann M
    Ophthalmology; 1999 Dec; 106(12):2322-4. PubMed ID: 10599665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' perspective of botulinum toxin-A as a long-term treatment option for neurogenic detrusor overactivity secondary to spinal cord injury.
    Hori S; Patki P; Attar KH; Ismail S; Vasconcelos JC; Shah PJ
    BJU Int; 2009 Jul; 104(2):216-20. PubMed ID: 19220255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Frey's syndrome with botulinum toxin.
    Pomprasit M; Chintrakarn C
    J Med Assoc Thai; 2007 Nov; 90(11):2397-402. PubMed ID: 18181326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of botulinum toxin type A injection into human masseter muscle on stimulated parotid saliva flow rate.
    Kwon JS; Kim ST; Jeon YM; Choi JH
    Int J Oral Maxillofac Surg; 2009 Apr; 38(4):316-20. PubMed ID: 19231136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum Toxin Injection for Chronic Parotitis: A Multi-Center and Prospective Trial.
    Kwon SY; Chun KJ; Kil HK; Oh KH; Kim C; Jang SJ; Kim MS
    Laryngoscope; 2021 Jun; 131(6):E1903-E1909. PubMed ID: 33111982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal hyperhidrosis of the anal fold: successful treatment with botulinum toxin A.
    Bechara FG; Sand M; Achenbach RK; Sand D; Altmeyer P; Hoffmann K
    Dermatol Surg; 2007 Aug; 33(8):924-7. PubMed ID: 17661934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bruxism secondary to brain injury treated with botulinum toxin-A: a case report.
    El Maaytah M; Jerjes W; Upile T; Swinson B; Hopper C; Ayliffe P
    Head Face Med; 2006 Nov; 2():41. PubMed ID: 17123443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of botulinum toxin therapy in otorhinolaryngology: experience from 1,000 treatments.
    Helmstaedter V; Wittekindt C; Huttenbrink KB; Guntinas-Lichius O
    Laryngoscope; 2008 May; 118(5):790-6. PubMed ID: 18300708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report.
    Xiao Z; Zhang F; Cui Z
    Aesthetic Plast Surg; 2009 May; 33(3):409-12. PubMed ID: 19357910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.